Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia

Cardiovascular Intervention and Therapeutics

Volumn 28, Issue 4, 2013, Pages 374-382

  Tomoi, Yusuke ^a   Soga, Yoshimitsu ^a   Iida, Osamu ^b   Hirano, Keisuke ^c   Suzuki, Kenji ^d   Kawasaki, Daizo ^e   Yamauchi, Yasutaka ^f   Miyashita, Yusuke ^g   Tazaki, Junichi ^h   Nobuyoshi, Masakiyo ^a  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

^b KANSAI ROSAI HOSPITAL   (Japan)

^c SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^d Sendai Kosei Hospital   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

^f SHINSHU UNIVERSITY   (Japan)

^g Kikuna Memorial Hospital   (Japan)

^h Graduate School of Medicine   (Japan)

Author keywords

Below the knee lesion; Critical limb ischemia; Endovascular therapy; Medical therapy; Statin

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CILOSTAZOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; WARFARIN;

ADVERSE OUTCOME; AGED; ARTICLE; BELOW THE KNEE DISEASE; BODY MASS; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DRUG EFFICACY; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERTENSION; JAPAN; LEG AMPUTATION; LIMB DISEASE; LIMB SALVAGE; MAJOR ADVERSE LIMB EVENT; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; REVASCULARIZATION; STENOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ENDOVASCULAR PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISCHEMIA; JAPAN; LEG; LIMB SALVAGE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84885199746     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-013-0188-6     Document Type: Article

References (24)

1. Al-Omran M, Tu JV, Johnston KW, et al. Use of interventional procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study. J Vasc Surg. 2003;38: 289-95.
2. Tomoharu Dohi, Osamu Iida, Shin Okamoto, Kiyonori Nanto, Shinsuke Nanto, Masaaki Uematsu. Mid-term clinical outcome following endovascular therapy in patients with chronic aortic occlusion. Cardiovasc Interv Ther. 2013 Mar 29 [Epub ahead of print].
3. Adam DJ, Beard JD, Cleveland T, et al. BASIL trial participants: bypass versus angioplasty in severe ischemic of the leg (BASIL): multicenter, randomized controlled trial. Lancet. 2005;366: 1925-34.
4. Giles KA, Pomposelli FB, Spence TL, Hamdan AD, Blattman SB, Panossian H, Schermerhorn ML. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic Intersociety Consensus class to outcome in 176 limbs. J Vasc Surg. 2008;48: 128-36.
5. Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 433 infrapopliteal procedures. Vascular. 2006;14: 63-9.
6. Conrad MF, Kang J, Cambria RP, Brewster DC, Watkins MT, Kwolek CJ, LaMuraglia GM. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg. 2009;50: 799-805.
7. Nakano Masatsugu, Muramatsu Toshiya, Hirano Keisuke, Tsukahara Reiko, Itou Yoshiaki, Ishimori Hiroshi. Six-month clinical outcomes after below-the-knee angioplasty for critical limb ischemia in patients on hemodialysis. Cardiovasc Interv Ther. 2010;25(2): 91-7.
8. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6): 738-43.
9. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high risk individuals: a randomized placebo-controlled trial. Lancet 2002, 360: 7-22.
10. Heart protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20536 people with peripheral arterial disease and other high risk conditions. J Vasc Surg. 2007;45: 645-54 discussion: 653-4.
11. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1): S1-75.
12. Fernandez N, McEnaney R, Marone LK, Rhee RY, Leers S, Makaroun M, Chaer RA. Multilevel versus isolated endovascular tibial interventions for critical limb ischemia. J Vasc Surg. 2011;54(3): 722-9.
13. Iida O, Soga Y, Hirano K, Kawasaki D, Suzuki K, Miyashita Y, et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vasc Surg. 2012;55(2): 363-70.
14. Kennedy J, Quan H, Buchan AM, Ghali WA, Feasby TE. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke. 2005;36: 2073-6.
15. McNally MM, Agle SC, Parker FM, Bogey WM, Powell CS, Stoner MC. Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair. J Vasc Surg. 2010;51(6): 1390-6.
16. Zhou Q, Liao JK. Pleiotropic effects of statins. Basic research and clinical perspectives. Circ J. 2010;74(5): 818-26.
17. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet. 2009;373: 1175-82.
18. Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, et al. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J. 2009;73: 2110-7.
19. Goodney PP, Likosky DS. Cronenwett JL; Vascular Study Group of Northern New England. Predicting ambulation status one year after lower extremity bypass. J Vasc Surg. 2009;49(6): 1431-9.
20. Fernandez Nathan, McEnaney Ryan, Marone Luke K, Rhee Robert Y, Leers Steven, Makaroun Michel, Chaer Rabih A. Predictors of failure and success of tibial interventions for critical limb ischemia. J Vasc Surg. 2010;52(4): 834-42.
21. Aielllo Fracesco A, Khan Asad A, Meltzer Andrew J, Gallagher Katherine A, McKinsey James F, Schneider Darren B, et al. Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia. J Vasc Surg. 2012;55: 371-80.
22. Iida O, Soga Y, Hirano K, Kawasaki D, Suzuki K, Miyashita Y, Nanto S, Uematsu M, et al. Midterm outcomes and risk stratification after endovascular therapy for patients with critical limb ischaemia due to isolated below-the-knee lesions. Eur J Vasc Endovasc Surg. 2012;43(3): 313-21.
23. Baigent Colin, Landray Martin J, Reith Christina, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377: 2181-92.
24. Fellström BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2010;362(15): 1450.